CASE NUMBER
8:2023bk80015
8:2023bk80015
TYPE / CHAPTER
Voluntary / 11
Voluntary / 11
Docket Entries by Month
| Dec 19, 2023 | 1 | Petition Non-individual Chapter 11 Voluntary Petition. Fee Amount $1738 Filed by Impel NeuroPharma Australia Pty Ltd Chapter 11 Plan due by 04/17/2024. Disclosure Statement due by 04/17/2024. (Patel, Rakhee) | |
|---|---|---|---|
| Dec 19, 2023 | Receipt of filing fee for Voluntary petition (chapter 11)( 23-80015-11) [misc,volp11a] (1738.00). Receipt number A30995392, amount $1738.00 (re: Doc# 1). (U.S. Treasury) | ||
| Dec 19, 2023 | 2 | Declaration re: Declaration for Electronic Filing of Bankruptcy Petition, Lists, Statements, and Schedules filed by Debtor Impel NeuroPharma Australia Pty Ltd (RE: related document(s)1 Voluntary petition (chapter 11)). (Patel, Rakhee) | |
| Dec 19, 2023 | 3 | Motion for joint administration of cases Impel NeuroPharma Australia Pty Ltd (Case No. 23-80015); Impel Pharmaceuticals Inc. (Case No. 23-80016) Debtors Emergency Motion for Entry of An Order (I) Directing Joint Administration of Chapter 11 Cases and (II) Granting Related Relief Filed by Debtor Impel NeuroPharma Australia Pty Ltd (Patel, Rakhee) | |
| Dec 20, 2023 | 4 | Notice of deficiency. Schedule A/B due 1/2/2024. Schedule D due 1/2/2024. Schedule E/F due 1/2/2024. Schedule G due 1/2/2024. Schedule H due 1/2/2024. Declaration Under Penalty of Perjury for Non-individual Debtors due 1/2/2024. Summary of Assets and Liabilities and Certain Statistical Information due 1/2/2024. Declaration for electronic filing due 1/2/2024. Statement of Financial Affairs due 1/2/2024. Creditor matrix due 12/22/2023. (Dozier, Bryan) | |
| Dec 21, 2023 | 6 | Order granting motion for joint administration lead case 8:23-bk-80016 with member case 8:23-bk-80015 (related document # 3). An order has been entered in accordance with Rule 1015(b) of the Federal Rules of Bankruptcy Procedure and Rule 1015-1 of the Local Bankruptcy Rules of the United States Bankruptcy Court for the Northern District of Texas directing joint administration for procedural purposes of the chapter 11 cases of each of the following: Impel Pharmaceuticals Inc., Case No. 23-80016 and Impel NeuroPharma Australia Pty Ltd, Case No. 23-80015. All further pleadings and other papers shall be filed in, and all further docket entries shall be made in, Case No. 23-80016 (SGJ). Entered on 12/21/2023. (Dugan, Sue) | |
| Dec 22, 2023 | 7 | BNC certificate of mailing. (RE: related document(s)4 Notice of deficiency. Schedule A/B due 1/2/2024. Schedule D due 1/2/2024. Schedule E/F due 1/2/2024. Schedule G due 1/2/2024. Schedule H due 1/2/2024. Declaration Under Penalty of Perjury for Non-individual Debtors due 1/2/2024. Summary of Assets and Liabilities and Certain Statistical Information due 1/2/2024. Declaration for electronic filing due 1/2/2024. Statement of Financial Affairs due 1/2/2024. Creditor matrix due 12/22/2023.) No. of Notices: 1. Notice Date 12/22/2023. (Admin.) |
Impel NeuroPharma Australia Pty Ltd
40 City Road
Floor 19, HWT Tower
Southbank
Victoria 3006
OUTSIDE U. S.
Australia
Rakhee V. Patel
Sidley Austin LLP
2021 McKinney Ave
Ste 2000
Dallas, TX 75201
214-981-3300
Fax : 214-981-3400
Email: rpatel@sidley.com
United States Trustee
1100 Commerce Street
Room 976
Dallas, TX 75202
214-767-8967
